DE602004018735D1 - Argon enthaltendes Arzneimittel zum Inhalieren und dessen Verwendung zur Behandlung von Neurotoxizität - Google Patents

Argon enthaltendes Arzneimittel zum Inhalieren und dessen Verwendung zur Behandlung von Neurotoxizität

Info

Publication number
DE602004018735D1
DE602004018735D1 DE602004018735T DE602004018735T DE602004018735D1 DE 602004018735 D1 DE602004018735 D1 DE 602004018735D1 DE 602004018735 T DE602004018735 T DE 602004018735T DE 602004018735 T DE602004018735 T DE 602004018735T DE 602004018735 D1 DE602004018735 D1 DE 602004018735D1
Authority
DE
Germany
Prior art keywords
argon
amphetamine
neurotoxicity
inhalation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004018735T
Other languages
English (en)
Inventor
Marc Lemaire
Jacques Abraini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Liquide Sante International SA
Original Assignee
Air Liquide Sante International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide Sante International SA filed Critical Air Liquide Sante International SA
Publication of DE602004018735D1 publication Critical patent/DE602004018735D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE602004018735T 2003-12-08 2004-12-01 Argon enthaltendes Arzneimittel zum Inhalieren und dessen Verwendung zur Behandlung von Neurotoxizität Active DE602004018735D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0350997A FR2863169B1 (fr) 2003-12-08 2003-12-08 Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications

Publications (1)

Publication Number Publication Date
DE602004018735D1 true DE602004018735D1 (de) 2009-02-12

Family

ID=34508773

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004018735T Active DE602004018735D1 (de) 2003-12-08 2004-12-01 Argon enthaltendes Arzneimittel zum Inhalieren und dessen Verwendung zur Behandlung von Neurotoxizität

Country Status (9)

Country Link
US (4) US20050152988A1 (de)
EP (2) EP2014293B1 (de)
AT (1) ATE418994T1 (de)
DE (1) DE602004018735D1 (de)
DK (1) DK2014293T3 (de)
ES (2) ES2320128T3 (de)
FR (1) FR2863169B1 (de)
PL (1) PL2014293T3 (de)
PT (2) PT1541156E (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
FR2863169B1 (fr) * 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
EP1980260A1 (de) * 2007-04-10 2008-10-15 Nicholas Peter Franks Verwendung hyperbarischer Bedingungen zur Bereitstellung von Neuroprotektion
EP1980261A1 (de) 2007-04-10 2008-10-15 Nicholas Peter Franks Verwendung von Helium mit Sauerstoff zur Bereitstellung von Neuroprotektion
US8435569B2 (en) 2007-04-30 2013-05-07 Nnoxe Pharmaceutiques Inc. Pharmaceutical composition comprising at least one thrombolytic agent (A) and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
ITMI20071031A1 (it) * 2007-05-22 2008-11-23 Acetilene & Deriv Ati Siad Spa Uso di xenon per la protezione di organi da danno ischemico
FR2929513B1 (fr) * 2008-04-02 2010-09-17 Air Liquide Traitement des migraines sans aura chez le femmes enceintes par inhalation de dioxygene gazeux.
WO2010035074A1 (en) * 2008-09-25 2010-04-01 Nnoxe Pharmaceutiques Inc Use of nitrous oxide, argon, xenon, helium, or neon, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents
FR2956323B1 (fr) 2010-02-15 2013-12-20 Air Liquide Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques
FR2960779A1 (fr) 2010-06-08 2011-12-09 Air Liquide Medicament gazeux inhalable a base de krypton contre les deficiences ou defaillances d'organes peripheriques
FR2964036B1 (fr) * 2010-08-24 2013-04-12 Air Liquide Medicament gazeux inhalable a base de krypton pour le traitement des neuro-intoxications
FR2975597B1 (fr) * 2011-05-24 2013-12-27 Air Liquide Utilisation de neon pour le traitement des neuro-intoxications, notamment des maladies enurodegeneratives et demyelinisantes
FR2976815A1 (fr) * 2011-06-27 2012-12-28 Air Liquide Medicament inhalable a base d'argon pour traiter ou prevenir les dyskinesies
FR2996457B1 (fr) * 2012-10-09 2019-11-29 L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Utilisation d'argon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996459B1 (fr) 2012-10-09 2015-02-06 Air Liquide Utilisation d'un melange argon/xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
PT2931291T (pt) 2012-12-11 2021-12-03 Mclean Hospital Corp Tratamento com xénon como complemento da psicoterapia para perturbações psiquiátricas
FR2999082A1 (fr) * 2012-12-12 2014-06-13 Air Liquide Utilisation d'argon combine a une hypothermie pour prevenir ou traiter les consequences neurologiques d'une asphyxie perinatale
GB201409085D0 (en) * 2014-05-21 2014-07-02 David Helene N Argon is a mu opioid receptor antagonist
CN107569509B (zh) * 2017-02-22 2018-09-21 滨州医学院 氙或氙气体混合物在制备治疗癫痫的制剂中的用途
FR3100714A1 (fr) 2019-09-12 2021-03-19 L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Argon associé à une thrombectomie en cas d’accident vasculaire cérébral ischémique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US584556A (en) * 1897-06-15 William a
SU1179997A1 (ru) * 1973-02-28 1985-09-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латсср Средство дл лечени паркинсонизма "глудантан
US3876773A (en) * 1973-05-15 1975-04-08 British Oxygen Co Ltd Gas mixtures containing nitrous oxide
FR2596989B1 (fr) * 1986-04-14 1990-05-18 Air Liquide Produit de radiosensibilisation des tissus biologiques en radiotherapie
AU2218997A (en) * 1996-03-22 1997-10-10 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands
US5846556A (en) * 1996-06-14 1998-12-08 Brooks; Bradley S. Inhalant for reducing stress and method of use
DE19910986C2 (de) * 1999-03-11 2001-06-07 Aga Ab Verwendung von Xenon bei der Behandlung von Neurointoxikationen
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
FR2863169B1 (fr) * 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications

Also Published As

Publication number Publication date
ATE418994T1 (de) 2009-01-15
PT2014293E (pt) 2013-05-07
DK2014293T3 (da) 2013-05-13
US20110086107A1 (en) 2011-04-14
ES2320128T3 (es) 2009-05-19
ES2405953T3 (es) 2013-06-04
EP2014293B1 (de) 2013-03-13
EP1541156B1 (de) 2008-12-31
US20140120184A1 (en) 2014-05-01
EP1541156A1 (de) 2005-06-15
PL2014293T3 (pl) 2013-07-31
FR2863169A1 (fr) 2005-06-10
US20070275089A1 (en) 2007-11-29
FR2863169B1 (fr) 2006-02-10
US20050152988A1 (en) 2005-07-14
EP2014293A1 (de) 2009-01-14
PT1541156E (pt) 2009-04-01

Similar Documents

Publication Publication Date Title
DE602004018735D1 (de) Argon enthaltendes Arzneimittel zum Inhalieren und dessen Verwendung zur Behandlung von Neurotoxizität
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
BR0313282A (pt) Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
EP2392322A3 (de) Dosierschemata für Trans-Clomiphen
WO2004006906A3 (en) Methods for the treatment of neoplasms
SG148850A1 (en) Methods of treating vascular disease
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
DE59508360D1 (de) Liposomal verkapseltes taxol, seine herstellung und seine verwendung
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
WO2006029036A3 (en) Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
ATE494042T1 (de) Behandlung von lungenerkrankungen mit gasförmigem mittel, das zur sättigung von gsno führt
RS20050344A (en) Treatment for hemorrhagic shock
HK1068606A1 (en) Novel aminobenzoephenones
MXPA04011835A (es) Tratamiento de combinacion para la depresion y ansiedad.
IL170519A (en) Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them
EP1637159A4 (de) Immunkompetenter zellaktivierungshemmer und seine verwendung
ATE386513T1 (de) Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie
DE69910600D1 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
PT1572686E (pt) Derivados de amida do ácido antranílico e suas utilizações farmacêuticas
DE60202299D1 (de) Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
TW200505427A (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof
WO2007095605A3 (en) Method for accelerating reentrainment of a circadian rhythm

Legal Events

Date Code Title Description
8364 No opposition during term of opposition